[Triptan treatment in migraine: a dose-based model for persistence and acute medication use patterns using nationwide health insurance data].

This research examined how patients in Hungary use triptans for migraine treatment. Researchers analyzed data from 7840 patients who had never used triptans before. They looked at medication use over three-month periods. The study focused on how often patients continued using triptans and how their dosages changed. They defined treatment discontinuation as not refilling prescriptions for over 90 days. The findings showed patterns in how patients manage their migraine medications. Many patients did not continue using triptans consistently. The research highlights the need for better understanding of treatment persistence. It also suggests that tracking medication usage can help improve migraine care. Overall, the study provides valuable insights into real-world triptan use among migraine sufferers. This could lead to better strategies for managing migraines and enhancing patient outcomes through tailored treatment approaches. Clinical relevance: This research highlights the importance of monitoring triptan use for better migraine management strategies.